Furthermore, BMSCs release IL-6 and IGF-1, which activate the signal transduction pathways that mediate drug resistance and increase the activation of HIF-1, affecting tumor metabolism and drug resistance [95,106,107,108,109,110,111,112,113,114]. Here, IGF1 is linked to neoplasm.